Trial intelligence / Profile preview

Pilot study of ropivacaine local infiltration anesthesia cardiac safety during total hip arthroplasty

NL-OMON38715Active, not recruiting

Sponsor
Reinier de Graaf Hospital
Start
Sep 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ropivacaine in hip osteoarthritis, sponsored by Reinier de Graaf Hospital. Primary endpoints: QRS widening and QTc interval change. Started Sep 2013; status: active, not recruiting.

02

Drugs

ropivacaine
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on NL-OMON38715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call